Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 233 entries
Sorted by: Best Match Show Resources per page
Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions.

Molecular syndromology

Esdal HCD, Ghbeis MB, Saltzman DA, Hess D, Hume JR, Reed RC, Berry SA, Hoggard E, Hirsch B, Baughn LB, Schimmenti LA.
PMID: 29928179
Mol Syndromol. 2018 May;9(3):141-148. doi: 10.1159/000488817. Epub 2018 Apr 28.

The pathogenesis of necrotizing enterocolitis (NEC) remains poorly understood but is thought to be multifactorial. There are no specific recurring chromosomal abnormalities previously associated with NEC. We report 3 cases of intestinal necrosis associated with large chromosome 6 deletions....

Cite
Esdal HCD, Ghbeis MB, Saltzman DA, et al. Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions. Mol Syndromol. 2018;9(3):141-148doi: 10.1159/000488817.
Esdal, H. C. D., Ghbeis, M. B., Saltzman, D. A., Hess, D., Hume, J. R., Reed, R. C., Berry, S. A., Hoggard, E., Hirsch, B., Baughn, L. B., & Schimmenti, L. A. (2018). Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions. Molecular syndromology, 9(3), 141-148. https://doi.org/10.1159/000488817
Esdal, Hannah C D, et al. "Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions." Molecular syndromology vol. 9,3 (2018): 141-148. doi: https://doi.org/10.1159/000488817
Esdal HCD, Ghbeis MB, Saltzman DA, Hess D, Hume JR, Reed RC, Berry SA, Hoggard E, Hirsch B, Baughn LB, Schimmenti LA. Necrotizing Enterocolitis in Two Siblings and an Unrelated Infant with Overlapping Chromosome 6q25 Deletions. Mol Syndromol. 2018 May;9(3):141-148. doi: 10.1159/000488817. Epub 2018 Apr 28. PMID: 29928179; PMCID: PMC6006637.
Copy Download .nbib Format: NLM
How Do PROMIS Scores Correspond to Common Physical Abilities?.

Clinical orthopaedics and related research

Brodke DJ, Zhang C, Shaw JD, Cizik AM, Saltzman CL, Brodke DS.
PMID: 34855330
Clin Orthop Relat Res. 2021 Nov 17; doi: 10.1097/CORR.0000000000002046. Epub 2021 Nov 17.

BACKGROUND: The Patient-Report Outcomes Measurement Information System (PROMIS) is increasingly used as a general-purpose tool for measuring orthopaedic surgery outcomes. This set of questionnaires is efficient, precise, and correlates well with specialty-specific measures, but impactful implementation of patient-specific data,...

Cite
Brodke DJ, Zhang C, Shaw JD, et al. How Do PROMIS Scores Correspond to Common Physical Abilities?. Clin Orthop Relat Res. 2021;doi: 10.1097/CORR.0000000000002046.
Brodke, D. J., Zhang, C., Shaw, J. D., Cizik, A. M., Saltzman, C. L., & Brodke, D. S. (2021). How Do PROMIS Scores Correspond to Common Physical Abilities?. Clinical orthopaedics and related research, . https://doi.org/10.1097/CORR.0000000000002046
Brodke, Dane J, et al. "How Do PROMIS Scores Correspond to Common Physical Abilities?." Clinical orthopaedics and related research vol. (2021). doi: https://doi.org/10.1097/CORR.0000000000002046
Brodke DJ, Zhang C, Shaw JD, Cizik AM, Saltzman CL, Brodke DS. How Do PROMIS Scores Correspond to Common Physical Abilities?. Clin Orthop Relat Res. 2021 Nov 17; doi: 10.1097/CORR.0000000000002046. Epub 2021 Nov 17. PMID: 34855330.
Copy Download .nbib Format: NLM
Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans.

Nature

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O'Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Neale BM, Daly MJ, MacArthur DG.
PMID: 33536625
Nature. 2021 Feb;590(7846):E53. doi: 10.1038/s41586-020-03174-8.

No abstract available.

Cite
Karczewski KJ, Francioli LC, Tiao G, et al. Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2021;590(7846):E53doi: 10.1038/s41586-020-03174-8.
Karczewski, K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alföldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., Walters, R. K., Tashman, K., Farjoun, Y., Banks, E., Poterba, T., Wang, A., Seed, C., Whiffin, N., Chong, J. X., Samocha, K. E., Pierce-Hoffman, E., Zappala, Z., O'Donnell-Luria, A. H., Minikel, E. V., Weisburd, B., Lek, M., Ware, J. S., Vittal, C., Armean, I. M., Bergelson, L., Cibulskis, K., Connolly, K. M., Covarrubias, M., Donnelly, S., Ferriera, S., Gabriel, S., Gentry, J., Gupta, N., Jeandet, T., Kaplan, D., Llanwarne, C., Munshi, R., Novod, S., Petrillo, N., Roazen, D., Ruano-Rubio, V., Saltzman, A., Schleicher, M., Soto, J., Tibbetts, K., Tolonen, C., Wade, G., Talkowski, M. E., Neale, B. M., Daly, M. J., & MacArthur, D. G. (2021). Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature, 590(7846), E53. https://doi.org/10.1038/s41586-020-03174-8
Karczewski, Konrad J, et al. "Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans." Nature vol. 590,7846 (2021): E53. doi: https://doi.org/10.1038/s41586-020-03174-8
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, Collins RL, Laricchia KM, Ganna A, Birnbaum DP, Gauthier LD, Brand H, Solomonson M, Watts NA, Rhodes D, Singer-Berk M, England EM, Seaby EG, Kosmicki JA, Walters RK, Tashman K, Farjoun Y, Banks E, Poterba T, Wang A, Seed C, Whiffin N, Chong JX, Samocha KE, Pierce-Hoffman E, Zappala Z, O'Donnell-Luria AH, Minikel EV, Weisburd B, Lek M, Ware JS, Vittal C, Armean IM, Bergelson L, Cibulskis K, Connolly KM, Covarrubias M, Donnelly S, Ferriera S, Gabriel S, Gentry J, Gupta N, Jeandet T, Kaplan D, Llanwarne C, Munshi R, Novod S, Petrillo N, Roazen D, Ruano-Rubio V, Saltzman A, Schleicher M, Soto J, Tibbetts K, Tolonen C, Wade G, Talkowski ME, Neale BM, Daly MJ, MacArthur DG. Author Correction: The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2021 Feb;590(7846):E53. doi: 10.1038/s41586-020-03174-8. PMID: 33536625; PMCID: PMC8064911.
Copy Download .nbib Format: NLM
Physician Consult Network.

The American journal of medicine

Saltzman L.
PMID: 32805231
Am J Med. 2021 Jan;134(1):e1. doi: 10.1016/j.amjmed.2020.07.018. Epub 2020 Aug 14.

No abstract available.

Cite
Saltzman L. Physician Consult Network. Am J Med. 2020;134(1):e1doi: 10.1016/j.amjmed.2020.07.018.
Saltzman, L. (2021). Physician Consult Network. The American journal of medicine, 134(1), e1. https://doi.org/10.1016/j.amjmed.2020.07.018
Saltzman, Leonard. "Physician Consult Network." The American journal of medicine vol. 134,1 (2021): e1. doi: https://doi.org/10.1016/j.amjmed.2020.07.018
Saltzman L. Physician Consult Network. Am J Med. 2021 Jan;134(1):e1. doi: 10.1016/j.amjmed.2020.07.018. Epub 2020 Aug 14. PMID: 32805231.
Copy Download .nbib Format: NLM
Effects of Electroconvulsive Therapy on Suicidal Behavior and Emergency Department Use Among Homeless Veterans: A Propensity Score-Matched Study.

The Journal of clinical psychiatry

Tsai J, Peltzman T, Watts BV, Shiner B.
PMID: 34705349
J Clin Psychiatry. 2021 Oct 26;82(6). doi: 10.4088/JCP.21m13935.

No abstract available.

Cite
Tsai J, Peltzman T, Watts BV, et al. Effects of Electroconvulsive Therapy on Suicidal Behavior and Emergency Department Use Among Homeless Veterans: A Propensity Score-Matched Study. J Clin Psychiatry. 2021;82(6)doi: 10.4088/JCP.21m13935.
Tsai, J., Peltzman, T., Watts, B. V., & Shiner, B. (2021). Effects of Electroconvulsive Therapy on Suicidal Behavior and Emergency Department Use Among Homeless Veterans: A Propensity Score-Matched Study. The Journal of clinical psychiatry, 82(6), . https://doi.org/10.4088/JCP.21m13935
Tsai, Jack, et al. "Effects of Electroconvulsive Therapy on Suicidal Behavior and Emergency Department Use Among Homeless Veterans: A Propensity Score-Matched Study." The Journal of clinical psychiatry vol. 82,6 (2021). doi: https://doi.org/10.4088/JCP.21m13935
Tsai J, Peltzman T, Watts BV, Shiner B. Effects of Electroconvulsive Therapy on Suicidal Behavior and Emergency Department Use Among Homeless Veterans: A Propensity Score-Matched Study. J Clin Psychiatry. 2021 Oct 26;82(6). doi: 10.4088/JCP.21m13935. PMID: 34705349.
Copy Download .nbib Format: NLM
Complications of Hardware Removal.

The Journal of bone and joint surgery. American volume

Kellam PJ, Harrast J, Weinberg M, Martin DF, Davidson NP, Saltzman CL.
PMID: 34398858
J Bone Joint Surg Am. 2021 Nov 17;103(22):2089-2095. doi: 10.2106/JBJS.20.02231.

BACKGROUND: While hardware removal may improve patient function, the procedure carries risks of unexpected outcomes. Despite being among the most commonly performed orthopaedic procedures, scant attention has been given to its complication profile.METHODS: We queried the American Board of...

Cite
Kellam PJ, Harrast J, Weinberg M, et al. Complications of Hardware Removal. J Bone Joint Surg Am. 2021;103(22):2089-2095doi: 10.2106/JBJS.20.02231.
Kellam, P. J., Harrast, J., Weinberg, M., Martin, D. F., Davidson, N. P., & Saltzman, C. L. (2021). Complications of Hardware Removal. The Journal of bone and joint surgery. American volume, 103(22), 2089-2095. https://doi.org/10.2106/JBJS.20.02231
Kellam, Patrick J, et al. "Complications of Hardware Removal." The Journal of bone and joint surgery. American volume vol. 103,22 (2021): 2089-2095. doi: https://doi.org/10.2106/JBJS.20.02231
Kellam PJ, Harrast J, Weinberg M, Martin DF, Davidson NP, Saltzman CL. Complications of Hardware Removal. J Bone Joint Surg Am. 2021 Nov 17;103(22):2089-2095. doi: 10.2106/JBJS.20.02231. PMID: 34398858.
Copy Download .nbib Format: NLM
Talar Dome Access Through Posteromedial Surgical Intervals for Fracture Care.

Foot & ankle international

DeKeyser GJ, O'Neill DC, Sripanich Y, Lenz AL, Saltzman CL, Haller JM, Barg A.
PMID: 34384278
Foot Ankle Int. 2021 Aug 12;10711007211036720. doi: 10.1177/10711007211036720. Epub 2021 Aug 12.

BACKGROUND: Posterior talar body fractures are rare injuries without a consensus surgical approach. This study evaluates the accessible area of the talar dome through 2 posteromedial approach intervals (posteromedial [PM] and modified posteromedial [mPM]) both with and without distraction.METHODS:...

Cite
DeKeyser GJ, O'Neill DC, Sripanich Y, et al. Talar Dome Access Through Posteromedial Surgical Intervals for Fracture Care. Foot Ankle Int. 2021;10711007211036720doi: 10.1177/10711007211036720.
DeKeyser, G. J., O'Neill, D. C., Sripanich, Y., Lenz, A. L., Saltzman, C. L., Haller, J. M., & Barg, A. (2021). Talar Dome Access Through Posteromedial Surgical Intervals for Fracture Care. Foot & ankle international, 10711007211036720. https://doi.org/10.1177/10711007211036720
DeKeyser, Graham J, et al. "Talar Dome Access Through Posteromedial Surgical Intervals for Fracture Care." Foot & ankle international vol. (2021): 10711007211036720. doi: https://doi.org/10.1177/10711007211036720
DeKeyser GJ, O'Neill DC, Sripanich Y, Lenz AL, Saltzman CL, Haller JM, Barg A. Talar Dome Access Through Posteromedial Surgical Intervals for Fracture Care. Foot Ankle Int. 2021 Aug 12;10711007211036720. doi: 10.1177/10711007211036720. Epub 2021 Aug 12. PMID: 34384278.
Copy Download .nbib Format: NLM
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, Witkiewicz AK, Maguire O, Minderman H, Nambiar R, Rosenheck HR, Knudsen ES, Muhitch JB, Abrams SI, Wang C, Hutson AD, Attwood K, Hicks KA, Jurcevic JA, Kalinski P, Iyer R, Boland PM.
PMID: 34645646
Clin Cancer Res. 2021 Dec 15;27(24):6726-6736. doi: 10.1158/1078-0432.CCR-21-1650. Epub 2021 Oct 13.

PURPOSE: We evaluated the antitumor efficacy of cetuximab in combination with pembrolizumab in patients with PATIENTS AND METHODS: In this phase Ib/II study, cetuximab was combined with pembrolizumab in patients with RASwt mCRC with ≥ one prior line of...

Cite
Fountzilas C, Bajor DL, Mukherjee S, et al. Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clin Cancer Res. 2021;27(24):6726-6736doi: 10.1158/1078-0432.CCR-21-1650.
Fountzilas, C., Bajor, D. L., Mukherjee, S., Saltzman, J., Witkiewicz, A. K., Maguire, O., Minderman, H., Nambiar, R., Rosenheck, H. R., Knudsen, E. S., Muhitch, J. B., Abrams, S. I., Wang, C., Hutson, A. D., Attwood, K., Hicks, K. A., Jurcevic, J. A., Kalinski, P., Iyer, R., & Boland, P. M. (2021). Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(24), 6726-6736. https://doi.org/10.1158/1078-0432.CCR-21-1650
Fountzilas, Christos, et al. "Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,24 (2021): 6726-6736. doi: https://doi.org/10.1158/1078-0432.CCR-21-1650
Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, Witkiewicz AK, Maguire O, Minderman H, Nambiar R, Rosenheck HR, Knudsen ES, Muhitch JB, Abrams SI, Wang C, Hutson AD, Attwood K, Hicks KA, Jurcevic JA, Kalinski P, Iyer R, Boland PM. Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clin Cancer Res. 2021 Dec 15;27(24):6726-6736. doi: 10.1158/1078-0432.CCR-21-1650. Epub 2021 Oct 13. PMID: 34645646.
Copy Download .nbib Format: NLM
Return-to-Sport Outcomes After Primary Ulnar Collateral Ligament Reconstruction With Palmaris Versus Hamstring Tendon Grafts: A Systematic Review.

Orthopaedic journal of sports medicine

Trofa DP, Constant M, Crutchfield CR, Dantzker NJ, Saltzman BM, Lynch TS, Ahmad CS.
PMID: 34881347
Orthop J Sports Med. 2021 Dec 02;9(12):23259671211055726. doi: 10.1177/23259671211055726. eCollection 2021 Dec.

BACKGROUND: Ulnar collateral ligament (UCL) reconstruction is the current gold standard of treatment for overhead athletes with a symptomatic, deficient UCL of the elbow who have failed nonoperative treatment and wish to return to sport (RTS) at a high...

Cite
Trofa DP, Constant M, Crutchfield CR, et al. Return-to-Sport Outcomes After Primary Ulnar Collateral Ligament Reconstruction With Palmaris Versus Hamstring Tendon Grafts: A Systematic Review. Orthop J Sports Med. 2021;9(12):23259671211055726doi: 10.1177/23259671211055726.
Trofa, D. P., Constant, M., Crutchfield, C. R., Dantzker, N. J., Saltzman, B. M., Lynch, T. S., & Ahmad, C. S. (2021). Return-to-Sport Outcomes After Primary Ulnar Collateral Ligament Reconstruction With Palmaris Versus Hamstring Tendon Grafts: A Systematic Review. Orthopaedic journal of sports medicine, 9(12), 23259671211055726. https://doi.org/10.1177/23259671211055726
Trofa, David P, et al. "Return-to-Sport Outcomes After Primary Ulnar Collateral Ligament Reconstruction With Palmaris Versus Hamstring Tendon Grafts: A Systematic Review." Orthopaedic journal of sports medicine vol. 9,12 (2021): 23259671211055726. doi: https://doi.org/10.1177/23259671211055726
Trofa DP, Constant M, Crutchfield CR, Dantzker NJ, Saltzman BM, Lynch TS, Ahmad CS. Return-to-Sport Outcomes After Primary Ulnar Collateral Ligament Reconstruction With Palmaris Versus Hamstring Tendon Grafts: A Systematic Review. Orthop J Sports Med. 2021 Dec 02;9(12):23259671211055726. doi: 10.1177/23259671211055726. eCollection 2021 Dec. PMID: 34881347; PMCID: PMC8646802.
Copy Download .nbib Format: NLM
Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation.

Microbiome

Tsou AM, Goettel JA, Bao B, Biswas A, Kang YH, Redhu NS, Peng K, Putzel GG, Saltzman J, Kelly R, Gringauz J, Barends J, Hatazaki M, Frei SM, Emani R, Huang Y, Shen Z, Fox JG, Glickman JN, Horwitz BH, Snapper SB.
PMID: 34732258
Microbiome. 2021 Nov 03;9(1):215. doi: 10.1186/s40168-021-01161-3.

BACKGROUND: The gut microbiome is altered in patients with inflammatory bowel disease, yet how these alterations contribute to intestinal inflammation is poorly understood. Murine models have demonstrated the importance of the microbiome in colitis since colitis fails to develop...

Cite
Tsou AM, Goettel JA, Bao B, et al. Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation. Microbiome. 2021;9(1):215doi: 10.1186/s40168-021-01161-3.
Tsou, A. M., Goettel, J. A., Bao, B., Biswas, A., Kang, Y. H., Redhu, N. S., Peng, K., Putzel, G. G., Saltzman, J., Kelly, R., Gringauz, J., Barends, J., Hatazaki, M., Frei, S. M., Emani, R., Huang, Y., Shen, Z., Fox, J. G., Glickman, J. N., Horwitz, B. H., & Snapper, S. B. (2021). Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation. Microbiome, 9(1), 215. https://doi.org/10.1186/s40168-021-01161-3
Tsou, Amy M, et al. "Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation." Microbiome vol. 9,1 (2021): 215. doi: https://doi.org/10.1186/s40168-021-01161-3
Tsou AM, Goettel JA, Bao B, Biswas A, Kang YH, Redhu NS, Peng K, Putzel GG, Saltzman J, Kelly R, Gringauz J, Barends J, Hatazaki M, Frei SM, Emani R, Huang Y, Shen Z, Fox JG, Glickman JN, Horwitz BH, Snapper SB. Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation. Microbiome. 2021 Nov 03;9(1):215. doi: 10.1186/s40168-021-01161-3. PMID: 34732258; PMCID: PMC8565002.
Copy Download .nbib Format: NLM
Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, Witkiewicz AK, Maguire O, Minderman H, Nambiar R, Rosenheck HR, Knudsen ES, Muhitch JB, Abrams SI, Wang C, Hutson AD, Attwood K, Hicks KA, Jurcevic JA, Kalinski P, Iyer R, Boland PM.
PMID: 34645646
Clin Cancer Res. 2021 Oct 13; doi: 10.1158/1078-0432.CCR-21-1650. Epub 2021 Oct 13.

PURPOSE: We evaluated the antitumor efficacy of cetuximab in combination with pembrolizumab in patients with PATIENTS AND METHODS: In this phase Ib/II study, cetuximab was combined with pembrolizumab in patients with RASwt mCRC with ≥ one prior line of...

Cite
Fountzilas C, Bajor DL, Mukherjee S, et al. Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1650.
Fountzilas, C., Bajor, D. L., Mukherjee, S., Saltzman, J., Witkiewicz, A. K., Maguire, O., Minderman, H., Nambiar, R., Rosenheck, H. R., Knudsen, E. S., Muhitch, J. B., Abrams, S. I., Wang, C., Hutson, A. D., Attwood, K., Hicks, K. A., Jurcevic, J. A., Kalinski, P., Iyer, R., & Boland, P. M. (2021). Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1650
Fountzilas, Christos, et al. "Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1650
Fountzilas C, Bajor DL, Mukherjee S, Saltzman J, Witkiewicz AK, Maguire O, Minderman H, Nambiar R, Rosenheck HR, Knudsen ES, Muhitch JB, Abrams SI, Wang C, Hutson AD, Attwood K, Hicks KA, Jurcevic JA, Kalinski P, Iyer R, Boland PM. Phase Ib/II Study of Cetuximab plus Pembrolizumab in Patients with Advanced RAS Wild-Type Colorectal Cancer. Clin Cancer Res. 2021 Oct 13; doi: 10.1158/1078-0432.CCR-21-1650. Epub 2021 Oct 13. PMID: 34645646.
Copy Download .nbib Format: NLM
Editorial.

Foot & ankle international

Saltzman CL.
PMID: 33406379
Foot Ankle Int. 2021 Jan;42(1):1. doi: 10.1177/1071100720977188.

No abstract available.

Cite
Saltzman CL. Editorial. Foot Ankle Int. 2021;42(1):1doi: 10.1177/1071100720977188.
Saltzman, C. L. (2021). Editorial. Foot & ankle international, 42(1), 1. https://doi.org/10.1177/1071100720977188
Saltzman, Charles L. "Editorial." Foot & ankle international vol. 42,1 (2021): 1. doi: https://doi.org/10.1177/1071100720977188
Saltzman CL. Editorial. Foot Ankle Int. 2021 Jan;42(1):1. doi: 10.1177/1071100720977188. PMID: 33406379.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 233 entries